The purpose of this study is to find out if a medicine called finerenone in combination with a medicine called empagliflozin is a safe and effective treatment for people that chronic kidney disease and type 2 diabetes.
Thank you for your interest, but this study is not currently enrolling.
North Carolina (Statewide)
Amy Mottl
Medicine-Nephrology
Clinical or Medical
Interventional
Diabetes
Kidneys and Liver
Rare Diseases
22-1479
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
